IL-1α plays a central role in the pathogenesis of ARDS in COVID-19: the release of IL-1α after the damage of the lung epithelium results in myeloid cell recruitment and inflammasome activation, leading to amplification of the inflammatory cascade. This evidence concerns the gene IL1A and COVID-19.